News

In accordance with the new agreement scientists from ChemBridge and AstraZeneca will work together to design and develop a new generation of highly advanced, research intensive small molecule

To begin leveraging a key part of the system right away, M D Anderson deployed Provantis Pathology using Instem’s remote hosted online model, allowing pathologists to access the

These applications include ultra-deep amplicon sequencing for detection of low-frequency mutations in disease associated genes, and the comprehensive identification and quantification of common and rare variants within a

In addition, the company has completed the relocation of its headquarters to 19204 North Creek Parkway, Suite 100 Bothell, Washington. The facility includes approximately 20,500sqft of R&D facilities

Most recently, Mr Pope served as worldwide president of Cordis, a multibillion dollar franchise within Johnson and Johnson’s medical device sector. Mr Pope is a graduate of the

As part of the agreement, the companies will utilize GE’s global research center and its advanced work in clinical parameters and monitoring algorithms to drive innovation in the

The trial was designed as a multi-centre, double-blind comparative study. Patients suffering from complicated skin and skin structure infections (cSSSI) received intravenous (IV) vancomycin for the first two

Each unit was priced at $7 and consisted of one share of PolyMedix convertible preferred stock and a five year warrant initially exercisable for one share of PolyMedix

Dr Geller brings to BioSpecifics extensive financial experience with biotechnology companies as he has served for over 15 years as a sell-side analyst and investment banker covering biotechnology